Yüklüyor......
Orally delivered polycurcumin responsive to bacterial reduction for targeted therapy of inflammatory bowel disease
Inflammatory bowel disease (IBD) such as Crohn’s disease and ulcerative colitis is a chronic autoimmune disease affecting nearly five million people worldwide. Among all drug delivery system, oral administration is the most preferable route for colon-specific targeting and the treatment of IBD. Here...
Kaydedildi:
| Yayımlandı: | Drug Deliv |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8240970/ https://ncbi.nlm.nih.gov/pubmed/28156160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2016.1245367 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|